CONFLICT OF INTEREST
SKIN
AbbVie participated in the study design; study research; collection, analysis, and interpretation of data; and writing, reviewing, and approving this manuscript for publication. All authors had access to the data, participated in the development and review of the document, and agreed in the decision to submit this manuscript for publication. No honoraria or payments were made for authorship. K.Y. has served as a clinical trials investigator for AbbVie, Boehringer Ingelheim, Eli Lilly Japan, LEO Pharma, Janssen, Maruho, MSD, Parexel, and UCB Japan. He has received research funding from AbbVie, Eisai, Eli Lilly Japan, Kyowa Kirin, Maruho, Sasaki Chemical, Sun Pharma, Taiho Yakuhin, and Torii Yakuhin. In addition, he has received speaker's fees and chair's fees from AbbVie, Astellas Seiyaku, Celgene, Daiichi‐Sankyo, Eisai, Eli Lilly Japan, Janssen, Kyowa‐Hakko Kirin, LEO Pharma, Maruho, Nippon Kayaku, Nippon Zouki, Novartis, Sun Pharma, Sato Seiyaku, Sanofi, Taiho Yakuhin, Tanabe Mitsubishi, and Torii Yakuhin. Y.O. has received grants from Eisai, Maruho, Shiseido, and Torii; consulting/advisory board fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol‐Myers Squibb, Eli Lilly, Janssen, and Sun Pharma; speakers' bureau fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eisai, Eli Lilly, Janssen, Jimro, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe, Novartis, Pfizer, Sanofi, Sun Pharma, Taiho, Torii, and UCB; and fees for participating in clinical trials sponsored by AbbVie, Amgen, Boehringer Ingelheim, Bristol‐Myers Squibb, Celgene, Eli Lilly, Janssen, LEO Pharma, Maruho, Pfizer, Sun Pharma, and UCB. I.Y., N.S., and I.M. are employees of AbbVie Inc. or AbbVie GK, and may hold AbbVie stock and/or stock options. A.M. has received honoraria from AbbVie, Ayumi Pharmaceutical, Boehringer Ingelheim, Celgene, Eisai, Eli Lilly, Inforward, Janssen, Kyowa Kirin, Maruho, Mitsubishi Tanabe, Nippon Kayaku, Novartis, Taiho, Torii, and Ushio. He has received research support from AbbVie, Eisai, Eli Lilly, Kyowa Hakko Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe, Novartis, Taiho Pharma, and Torii. He has also served as a consultant for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Janssen, Kyowa Kirin, Maruho, Mitsubishi Tanabe, Nichi‐Iko Pharmaceutical, Nippon Kayaku, Novartis, NPO Health Institute Research of Skin, Pfizer, Sun Pharma, Torii, and UCB.